In particular, we exhibited the direct implication of NR5A2 in the activation of specific genes of the Ink4/Arf locus in NSCs, one of the most significant tumour suppressor loci in many organs, including brain cancers, glioblastomas and retinoblastomas39, 40, 41, 42. This evidence concerns the gene NR5A2 and brain cancer.